Imke H. Bartelink
- Hematology top 2%
- Hematopoietic Stem Cell Transplantation 14
- Chronic Myeloid Leukemia Treatments 7
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments 5
- Pharmacology top 2%
- Antibiotics Pharmacokinetics and Efficacy 9
- Pharmacogenetics and Drug Metabolism 6
- Oncology top 5%
-
- Acute Lymphoblastic Leukemia research 10
-
- Chronic Lymphocytic Leukemia Research 5
-
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Jaap Jan BoelensCarin M. A. RademakerJohn N. van den AnkerAlfred F.A.M. SchobbenToine C. G. EgbertsRobbert G. M. BrediusMarc BieringsCatherijne A. J. Knibbe
- Journals
- Journal of Clinical Oncology (4 papers)American Journal of Respiratory and Critical Care Medicine (1 paper)Scientific Reports (1 paper)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Imke H. Bartelink
61 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 127
- Hematology 526
- Transplantation 91
- Pharmacology 187
- Pediatrics, Perinatology and Child Health 396
- Oncology 458
Countries citing papers authored by Imke H. Bartelink
This map shows the geographic impact of Imke H. Bartelink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imke H. Bartelink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imke H. Bartelink more than expected).
Fields of papers citing papers by Imke H. Bartelink
This network shows the impact of papers produced by Imke H. Bartelink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imke H. Bartelink. The network helps show where Imke H. Bartelink may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Imke H. Bartelink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 6 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 15 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 15 | |
| 12 | 2019 | 51 | |
| 13 | 2019 | 71 | |
| 14 | 2017 | 76 | |
| 15 | 2017 | 58 | |
| 16 | 2014 | 74 | |
| 17 | 2014 | 66 | |
| 18 | 2013 | 51 | |
| 19 | 2012 | 87 | |
| 20 | 2007 | 58 |
About Imke H. Bartelink
Imke H. Bartelink is a scholar working on Hematology, Transplantation and Oncology, having authored 64 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (14 papers), Acute Lymphoblastic Leukemia research (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Chronic Myeloid Leukemia Treatments (7 papers), Pharmacogenetics and Drug Metabolism (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Hematology (526 citations), Transplantation (91 citations) and Pharmacology (187 citations). Imke H. Bartelink has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Jaap Jan Boelens, Carin M. A. Rademaker, John N. van den Anker, Alfred F.A.M. Schobben, Toine C. G. Egberts, Robbert G. M. Bredius, Marc Bierings, Catherijne A. J. Knibbe, J. Zwaveling and Paolo Vicini. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.